BioSpace News Archive

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000

On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory was inaugurated in Harbin, Heilongjiang province, China, marking a significant advance in the province’s efforts to address public health challenges.

May 13, 2024
·
2 min read
Pharm Country

Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranor

Inventiva announced the publication in the peer-reviewed scientific journal Nature Communications of additional results from its NATIVE Phase IIb clinical trial demonstrating the improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranor.

May 13, 2024
·
18 min read
Business

ERS Genomics Appoints John E Milad as Chief Executive Officer

ERS Genomics Limited, the CRISPR licensing company, announced the appointment of John E Milad as CEO, with immediate effect.

May 13, 2024
·
3 min read
Biotech Bay

Meditrina Welcomes Senior Vice President of Global Sales to Lead Expansion Efforts and Manage Rapid Growth

Meditrina, a leader in gynecologic medical devices, announced the expansion of its leadership team with the hiring of Ray Gerena, as Senior Vice President of Global Sales.

May 13, 2024
·
2 min read
Policy

Meditrina Announces CE Mark Approval and First Multi-International Cases Performed

Meditrina, a leading innovator in gynecologic medical devices, announces the successful receipt of UKCA Mark, and CE Mark approval in accordance with Regulation 20147/745, for its state-of-the-art Aveta Hysteroscopy System.

May 13, 2024
·
3 min read
Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions

Allozymes, a leading innovator in enzyme discovery and engineering, announced the closing of a $15 million Series A funding round led by Seventure Partners of France and Xora Innovation of Singapore.

May 13, 2024
·
3 min read
Business

Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

Belite Bio, Inc announced its financial results for the first quarter ended March 31, 2024 and provided a general business update.

May 13, 2024
·
10 min read
Business

PAVmed Provides Business Update and First Quarter 2024 Financial Results

PAVmed Inc. (NASDAQ: PAVM, PAVMZ) (“PAVmed” or the “Company”) today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) (“Lucid”) and Veris Health Inc. (“Veris”), and presented financial results for the Company for the three months ended March 31, 2024.

May 13, 2024
·
10 min read
Deals

Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies

Stereotaxis announced that it has entered into a definitive share purchase agreement under which Stereotaxis will acquire Access Point Technologies EP, a privately-held Minnesota-based developer of innovative electrophysiology catheters.

May 13, 2024
·
6 min read
Business

Stereotaxis Reports 2024 First Quarter Financial Results

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first quarter ended March 31, 2024.

May 13, 2024
·
7 min read